ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664529 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664529; 2) Community: the network communities that were significantly associated with the response to NSC 664529; 3) Molecule: the relationships between components within communities and NSC 664529; 4) MDR: the compounds that were significantly associated with the NSC 664529.

NSC Compound Enrichment Correlation
NSC 40273 Null 0.00896740831404549 0.32874751
NSC 405158 2,5-Cyclohexadiene-.delta.1,.alpha.-acetonitrile, .alpha.-(p-chlorophenyl)-4-oxo-, oxime 0.00896740831404549 0.26912237
NSC 606172 Camptothecin Derivative 0.00896740831404549 0.3324145
NSC 616348 Irinotecan hydrochloride 0.00896740831404549 0.20305255
NSC 618939 Camptothecin Derivative 0.00896740831404549 0.31548671
NSC 621321 Null 0.00896740831404549 0.33684432
NSC 626108 Null 0.00896740831404549 -0.14691273
NSC 646127 6H-Pyrido[4,3-b]carbazole, 1,2-dihydro-2,5,9,11-tetra- methyl- 0.00896740831404549 -0.15809845
NSC 658725 Null 0.00896740831404549 0.27053103
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.00896740831404549 0.35239547
Total:121  Current:33    [First] [Prev] [Next] [Last]